Image

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect

Recruiting
18-90 years
All
Phase N/A

Powered by AI

Overview

The investigators aim to elucidate characteristics of structural and functional brain connectivity in patients with amyotrophic lateral sclerosis (ALS) and pseudobulbar affect (PBA) using diffusion kurtosis imaging (DKI) and magnetoencephalography (MEG).

Eligibility

Inclusion Criteria:

  • Diagnosed with ALS in the last 6 months according to Gold Coast Criteria

Exclusion Criteria:

  • - Lack of ability to answer survey through own ability or through a surrogate, for example by hand controlled, eye-controlled computer and/or tablet, or through telephone interview.
  • Lack of ability to cooperate.
  • Pregnancy
  • Drug addiction defined as the non-prescribed use of cannabis, opioids, or other narcotics.
  • Alcohol addiction defined as over 21 units weekly.
  • Lesional neurological diseases, such as stroke, tumor or multiple sclerosis
  • Epilepsy
  • Neurodegenerative diseases other than ALS
  • Severe psychiatric disease such as major depression disorder, bipolar disease or schizophrenia
  • Contraindication for MRI and MEG scan according to hospital guidelines
  • Severe liver or kidney disease
  • Dysregulated heart disease
  • Ongoing treatment with any antidepressants or any antipsychotics at recruitment.
  • Diagnosed with frontotemporal dementia.

Study details
    Amyotrophic Lateral Sclerosis
    Pseudobulbar Affect

NCT06396260

Aalborg University Hospital

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.